Javascript must be enabled to continue!
Assessment of Programmed Cell Death (PD-1) and its Ligand’s (PD-L1) levels in vitiligo
View through CrossRef
Abstract
Background: Programmed cell death 1 (PD-1) is a cell surface protein that serves as an immune checkpoint in conjunction with its two ligands, PD-L1 and PD-L2. Recently, there has been a lot of interest in the role of the PD-1/PD-L1 pathway in immunoregulation. When PD-1/PD-L1 pathway inhibitors were used in cancer therapy, the observed aggravation of the pre-existing autoimmune disease and the emergence of autoimmune-like symptoms shed light on the potential therapeutic role of increasing PD-L1 expression or activating PD-1 in the fight against diseases with autoimmune pathology, including vitiligo. The present study aimed to assess both PD-1 and PD-L1 levels in vitiligo patients’ marginal and non-lesional biopsies in comparison with normal controls and to correlate them with disease parameters.
Methods: Thirty vitiliginous patients and 30 age and sex-matched controls were included. Full history and clinical examination were done and tissue levels of PD-1 and PD-L1 were measured by ELISA from lesional and non-lesional biopsies.
Results: Levels of tissue PD-1 in marginal biopsies were significantly higher than in non-lesional biopsies (p< .001) and significantly higher than the control PD-l level (p< .001). Non-lesional PD-1 level was also significantly higher than the control PD-l level (p< .001). A statistically significant positive correlation was found between marginal and non-lesional PD-1 levels; (rho=0.792, p< .001). Levels of tissue PD-1 in non-lesional biopsies were significantly higher than in controls (P<0.001) and levels of tissue PD-L1 in non-lesional biopsies were significantly lower than in controls (P<0.001). Non-lesional PD-L1 level was also significantly higher than the control PD-Ll level (p< .001).
Research Square Platform LLC
Title: Assessment of Programmed Cell Death (PD-1) and its Ligand’s (PD-L1) levels in vitiligo
Description:
Abstract
Background: Programmed cell death 1 (PD-1) is a cell surface protein that serves as an immune checkpoint in conjunction with its two ligands, PD-L1 and PD-L2.
Recently, there has been a lot of interest in the role of the PD-1/PD-L1 pathway in immunoregulation.
When PD-1/PD-L1 pathway inhibitors were used in cancer therapy, the observed aggravation of the pre-existing autoimmune disease and the emergence of autoimmune-like symptoms shed light on the potential therapeutic role of increasing PD-L1 expression or activating PD-1 in the fight against diseases with autoimmune pathology, including vitiligo.
The present study aimed to assess both PD-1 and PD-L1 levels in vitiligo patients’ marginal and non-lesional biopsies in comparison with normal controls and to correlate them with disease parameters.
Methods: Thirty vitiliginous patients and 30 age and sex-matched controls were included.
Full history and clinical examination were done and tissue levels of PD-1 and PD-L1 were measured by ELISA from lesional and non-lesional biopsies.
Results: Levels of tissue PD-1 in marginal biopsies were significantly higher than in non-lesional biopsies (p< .
001) and significantly higher than the control PD-l level (p< .
001).
Non-lesional PD-1 level was also significantly higher than the control PD-l level (p< .
001).
A statistically significant positive correlation was found between marginal and non-lesional PD-1 levels; (rho=0.
792, p< .
001).
Levels of tissue PD-1 in non-lesional biopsies were significantly higher than in controls (P<0.
001) and levels of tissue PD-L1 in non-lesional biopsies were significantly lower than in controls (P<0.
001).
Non-lesional PD-L1 level was also significantly higher than the control PD-Ll level (p< .
001).
Related Results
The positive correlation between serum malondialdehyde levels with vitiligo severity and activity
The positive correlation between serum malondialdehyde levels with vitiligo severity and activity
Background: There are several theories that suggest melanocyte death in vitiligo, one example is oxidative stress theory. Oxidative stress primarily manifested by lipid peroxidatio...
Does the Saudi Population Have Sufficient Awareness of Vitiligo in Southwest Saudi Arabia? A Cross-Sectional Survey, 2022
Does the Saudi Population Have Sufficient Awareness of Vitiligo in Southwest Saudi Arabia? A Cross-Sectional Survey, 2022
Background: Vitiligo is a common acquired hypopigmentation skin condition defined by an idiopathic, gradual, and restricted loss of melanin pigment from otherwise healthy-looking s...
Assessment of Serum Brain-Derived Neurotrophic Factor Level and Its Relation to Psychiatric Morbidity in Vitiligo Patients and the Effect of Vitiligo on the Quality of Life
Assessment of Serum Brain-Derived Neurotrophic Factor Level and Its Relation to Psychiatric Morbidity in Vitiligo Patients and the Effect of Vitiligo on the Quality of Life
Abstract
Background
Vitiligo is a chronic skin disorder with depigmentation of skin patches. Vitiligo exerts a huge burden on th...
Prevalence of programmed death ligand-1 in patients diagnosed with non-small cell lung cancer in Lebanon
Prevalence of programmed death ligand-1 in patients diagnosed with non-small cell lung cancer in Lebanon
Introduction:
Programmed death ligand-1 expression has been shown to be a good predictor of response to cancer therapy with checkpoint inhibitors. Its expressio...
Clinico-epidemiology vitiligo profile in childhood at Mangusada General Hospital Badung
Clinico-epidemiology vitiligo profile in childhood at Mangusada General Hospital Badung
Introduction: Vitiligo is a depigmentation disorder characterized by well-demarcated white macules and patches on the skin. Vitiligo commonly occurs in children or young adults. Vi...
The Impact of Psychological Stress on Vitiligo Activity and Severity in Saudi Arabia: A Cross-Sectional Study
The Impact of Psychological Stress on Vitiligo Activity and Severity in Saudi Arabia: A Cross-Sectional Study
Introduction: Psychological stress has been associated with various chronic diseases and its role in the onset and progression of vitiligo has also been proposed. However, little i...
CXCL10 As A Potential Marker of Disease Activity in Pediatric Vitiligo
CXCL10 As A Potential Marker of Disease Activity in Pediatric Vitiligo
Introduction: Vitiligo is a common acquired depigmentary inflammatory disorder associated with negative psychosocial impacts in children and their caregivers. C-X-C motif chemokine...
Public Knowledge and Attitudes towards Vitiligo: A Survey in Mekelle City, Northern Ethiopia
Public Knowledge and Attitudes towards Vitiligo: A Survey in Mekelle City, Northern Ethiopia
Background. The overall well-being, sense of stigmatization, and treatment outcome of persons with vitiligo are largely dependent on their social acceptance and this is linked with...

